HopeStage
Back to all studies
CompletedNCT04278586

Online Mindfulness During Buprenorphine Treatment

About this titleRead the official source — NCT04278586
Behavioural studyAges 18–70United StatesAnxiety
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
SomervilleSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 15, 2021
Recruitment status
Completed
Enrollment listed in the registry
260
Sponsor
Cambridge Health Alliance
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Behavioural
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT04278586
Official title
Show the full official title

Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Somerville

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Cambridge Health Alliance.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies